Correction to: DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach

Affiliations

• ¹ Centre for Respiratory Medicine and Allergy, Institute of Inflammation and Repair, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
• ² Manchester University NHS Foundation Trust, Manchester, UK.
• ³ Pulmonology Unit, Hospital General de Agudos Dr. J. A. Fernández, Buenos Aires, Argentina.
• ⁴ Universidad Anáhuac, Querétaro, México.
• ⁵ Universidad Autónoma de Nuevo León, Servicio de Neumología, CIPTIR, Monterrey, NL, México.
• ⁶ Department of Chest Diseases, Ege University Faculty of Medicine, İzmir, Turkey.
• ⁷ Department of Botucatu Medical School, Universidade Estadual Paulista, São Paulo, Brazil.
• ⁸ Emerging Markets, GSK, Singapore, Singapore.
• ⁹ Value Evidence and Outcomes, GSK, Collegeville, PA, USA.
• ¹⁰ Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
• ¹¹ GSK, Brentford, UK.
• ¹² Clinical Pharmacology and Experimental Medicine, GSK, Brentford, London, UK. peter.t.daley-yates@hotmail.com.